Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03626324 · ClinicalTrials.gov registry record · NA
Connected Catheter (C2P) Study for Bladder Management
A NA study, sponsored by Spinal Singularity.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03626324: Completed NA study, sponsored by Spinal Singularity.
NCT03626324 is a NA study that has completed, run by Spinal Singularity. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03626324, a NA study, has completed, sponsored by Spinal Singularity.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and essential performance of the C2P System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting and an extended period of home use.
Primary Outcome
Improved bladder management without injury to genito-urinary tract
Interventions
- DEVICE C2P
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-07-25 |
| Est. Completion | 2019-01-31 |
| Phase | NA |
What the finished NCT03626324 record still lists
NCT03626324 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which C2P is the first listed.
NCT03626324 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03626324 about?
NCT03626324 is a clinical study titled "Connected Catheter (C2P) Study for Bladder Management". The objective of this study is to evaluate the safety and essential performance of the C2P System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting and an extended period of home use.
What is the current status of trial NCT03626324?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-07-25. Estimated completion is 2019-01-31.
What interventions are being tested in trial NCT03626324?
The interventions under investigation include: C2P (DEVICE).
Who is sponsoring clinical trial NCT03626324?
This trial is sponsored by Spinal Singularity, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03626324's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI